NCT04644770 2026-03-13
A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer
Janssen Research & Development, LLC
Phase 1 Active not recruiting
Clinical Trials
7 trialsNCT07426055 2026-02-23
PRO-BOOST-LC
Affidea Nu-med Center of Oncological DIagnostics and Therapy
Phase 2/3 Not yet recruiting
NCT07219303 2025-10-29
DE-CART
Fox Chase Cancer Center
Phase NA Recruiting
NCT06665932 2024-11-12
Stereotactic Radiotherapy of Prostate Cancer With Reduction of Safety Margins
University Hospital Ostrava
Phase NA Recruiting
NCT02653248 2022-02-09
SBRT for Organ Confined Prostate Cancer
Northwell Health
Phase 1 Completed
NCT01511081 2017-12-07
Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT)
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00230347 2010-04-01
Evaluation of Stereotactic Radiosurgery For Liver Malignancies
Stanford University
Phase 1 Completed